The Dogs Who Cannot Take the Standard Pain Drug
NSAIDs remain the cornerstone of chronic pain management for canine arthritis. But a large subset of senior dogs cannot tolerate them long-term: those with kidney disease, liver disease, GI sensitivity, or concurrent corticosteroid use (which raises GI bleeding risk 4-fold). Others have pain severe enough that NSAIDs alone cannot control it.
These patients are common in aging populations. For them, alternative and adjunctive pain management is not optional — it is essential for maintaining quality of life and functional independence. The good news: multiple effective options exist, and the most successful approach combines several of them.
Why Combining Modest Effects Beats Any Single Drug
The most effective chronic pain management uses multiple agents and modalities that target different pain pathways simultaneously. This is called multimodal analgesia. By combining lower doses of multiple interventions, each targeting a different mechanism, total pain relief can exceed what any single agent achieves alone, often with fewer side effects.
Lascelles et al. (2008) demonstrated that multimodal approaches improve pain scores in dogs with osteoarthritis more effectively than single-agent therapy.
Four Pharmaceutical Alternatives Worth Knowing
Gabapentin
Mechanism: Modulates calcium channels in the central nervous system, reducing neuropathic and central sensitization pain. Evidence: Monteiro et al. (2022) systematic review found moderate evidence for gabapentin’s analgesic efficacy in dogs, particularly for neuropathic pain components and central sensitization. Dosing: Typically 5-10 mg/kg, 2-3 times daily. Sedation is the most common side effect and usually resolves within 3-5 days. Best for: Dogs with neuropathic pain, intervertebral disc disease, chronic arthritis with central sensitization, or as an NSAID adjunct.
Amantadine
Mechanism: NMDA receptor antagonist that reduces central sensitization (wind-up pain). Evidence: A 2012 study (Lascelles et al.) showed that adding amantadine to meloxicam improved pain scores in dogs with refractory osteoarthritis. Dosing: 3-5 mg/kg once daily. Best for: Dogs whose pain is incompletely controlled by NSAIDs alone, or as a replacement when NSAIDs are contraindicated.
Tramadol
Mechanism: Weak mu-opioid receptor agonist with serotonin and norepinephrine reuptake inhibition. Evidence: Controversial in dogs. Canine tramadol metabolism produces minimal active M1 metabolite (unlike humans), meaning the opioid component is weak. Some analgesic effect likely comes from the monoamine reuptake mechanism. Evidence suggests it is less effective than previously believed for orthopedic pain in dogs. Dosing: 2-5 mg/kg, 2-3 times daily. Best for: Mild to moderate pain, short-term use, or as one component of a multimodal protocol. Should not be sole long-term analgesic for significant pain.
Anti-Nerve Growth Factor (Anti-NGF) Antibodies
Mechanism: Monoclonal antibodies targeting nerve growth factor, which is elevated in chronic pain states. Evidence: Bedinvetmab (Librela) was FDA-approved for dogs in 2023 specifically for osteoarthritis pain. Clinical trials showed significant pain score improvement compared to placebo, with once-monthly subcutaneous injection. Dosing: Weight-based, administered monthly by injection. Best for: Dogs with osteoarthritis who cannot tolerate NSAIDs. Represents a genuinely new mechanism in veterinary pain management.
Beyond Medication: Physical and Environmental Interventions
Physical Rehabilitation
Rehabilitation therapy has the strongest evidence base among non-pharmaceutical pain interventions:
- Underwater treadmill: Reduces joint loading while maintaining muscle conditioning. See water treadmill hydrotherapy.
- Therapeutic laser (photobiomodulation): Evidence supports modest pain reduction and improved healing in dogs with arthritis. See therapeutic laser evidence.
- Manual therapy: Targeted massage, range of motion exercises, and joint mobilization performed by certified rehabilitation therapists.
- Transcutaneous electrical nerve stimulation (TENS): Some evidence for acute pain relief, less clear for chronic pain.
Acupuncture
Veterinary acupuncture has moderate evidence for chronic pain management in dogs, particularly for musculoskeletal pain and some neurological conditions. See acupuncture for dogs for the evidence review. Effect sizes are generally modest, and response is individual — some dogs show significant improvement while others show minimal response.
Environmental Modification
Not a treatment per se, but essential for quality of life:
- Orthopedic beds with memory foam or supportive surfaces
- Non-slip mats and rugs on hard floors
- Ramps for car access and elevated surfaces
- Elevated food and water bowls for dogs with neck or spinal pain
- Controlled indoor temperature (cold worsens arthritis pain)
Nutraceutical Support
Omega-3 Fatty Acids
EPA and DHA have documented anti-inflammatory effects in dogs with arthritis. At therapeutic doses (50-75 mg/kg/day EPA+DHA), they reduce prostaglandin production through a mechanism complementary to NSAIDs. See omega-3 for dogs. This is the nutraceutical with the strongest evidence base for pain-related inflammation.
Glucosamine and Chondroitin
Evidence in dogs is mixed. Some studies show modest improvement in pain scores; others show no benefit over placebo. Effect size, if present, is small. May provide modest structural support for cartilage. See glucosamine-chondroitin for dogs.
Curcumin
Anti-inflammatory in vitro, but bioavailability in dogs is very poor without specialized formulations. Enhanced bioavailability products (liposomal, phospholipid-complexed) may provide modest benefit. See curcumin for dogs.
CBD
Emerging evidence suggests modest analgesic effects for canine osteoarthritis pain, with two controlled trials showing improved pain scores compared to placebo. Quality and dosing consistency vary dramatically between products. See CBD evidence for dogs.
Sample Protocol: Moderate Arthritis, NSAID-Intolerant Dog
For a typical dog with moderate chronic arthritis pain who cannot tolerate NSAIDs:
- Gabapentin (5-10 mg/kg BID-TID) for central pain modulation
- Bedinvetmab (monthly injection) for peripheral nerve growth factor blockade
- Omega-3 fatty acids (50-75 mg/kg/day EPA+DHA) for anti-inflammatory support
- Physical rehabilitation (underwater treadmill 1-2x/week, home exercises daily)
- Environmental modification (orthopedic bed, ramps, non-slip surfaces)
- Weight management to BCS 4-5/9 — reducing body weight by 10% measurably reduces joint pain
Common Mistakes
- Accepting poorly controlled pain as inevitable in senior dogs. Multiple effective alternatives exist when NSAIDs are contraindicated.
- Using tramadol as a sole long-term analgesic. Evidence for its efficacy as a standalone agent in dogs is weak.
- Trying one alternative, declaring it ineffective, and giving up. Multimodal approaches combine modest individual effects into meaningful cumulative pain relief.
- Ignoring weight management as pain treatment. Excess weight is the single most modifiable pain amplifier in arthritic dogs.
Frequently Asked Questions
Can my dog take gabapentin long-term?
Yes. Gabapentin has a favorable long-term safety profile in dogs. Initial sedation typically resolves within 3-5 days. Periodic blood work (every 6-12 months) is recommended for dogs on chronic gabapentin, primarily as general senior monitoring rather than for gabapentin-specific toxicity.
Is Librela (bedinvetmab) safe for dogs with kidney disease?
Anti-NGF antibodies like bedinvetmab are not metabolized through the kidneys, making them a useful option for dogs who cannot tolerate NSAIDs due to renal compromise. However, discuss with your veterinarian — all medications require individual risk assessment.
What is the best alternative to NSAIDs for arthritis pain?
There is no single best alternative. The most effective approach is multimodal: combining gabapentin or bedinvetmab with omega-3 supplementation, physical rehabilitation, weight management, and environmental modification. The combination usually provides better pain relief than any single agent.
Can supplements replace pain medication?
For mild pain, some dogs may be adequately managed with omega-3 fatty acids, weight optimization, and rehabilitation alone. For moderate to severe pain, supplements should be viewed as adjuncts to pharmaceutical pain management, not replacements.
How do I know if my dog’s pain management is adequate?
Track functional indicators: willingness to walk, ability to rise from lying, stair navigation, play behavior, sleep quality, and appetite. If these are maintained or improving, pain management is likely adequate. If they are declining despite treatment, reassess with your veterinarian. See pain assessment in senior dogs.
Bottom Line
Effective chronic pain management exists beyond NSAIDs. Gabapentin, amantadine, anti-NGF antibodies (bedinvetmab), physical rehabilitation, omega-3 fatty acids, and environmental modification provide multiple mechanisms for pain control that can be combined into multimodal protocols. The most important principle is that no senior dog should live with uncontrolled pain simply because they cannot tolerate NSAIDs — alternatives exist and should be actively pursued.